Stay updated with breaking news from Bobby Sheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bora Pharmaceuticals Co., Ltd. yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics manufacturer based in Minnesota, U.S., from its previous owners, Sawai Group Holdings and Sumitomo Corporation of Americas.
Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion.
Transaction is set to fuel global expansion
Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth and Maple Grove, Minn.
Bringing Taiwan to the World and the World to Taiwan